首页> 外文期刊>Journal of neurosurgical anesthesiology >Recovery from anesthesia after craniotomy for supratentorial tumors: Comparison of propofol-remifentanil and sevoflurane-sufentanil (the promiflunil trial)
【24h】

Recovery from anesthesia after craniotomy for supratentorial tumors: Comparison of propofol-remifentanil and sevoflurane-sufentanil (the promiflunil trial)

机译:幕上肿瘤开颅手术后麻醉后的恢复:丙泊酚-瑞芬太尼和七氟醚-舒芬太尼的比较(promiflunil试验)

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION:: Rapid recovery after supratentorial tumors (STT) removal is important. Short-acting anesthetics, such as propofol and remifentanil might favor this objective. The aim of this study was to compare the recovery of 2 Bispectral index (BIS)-guided anesthesia protocols combining sevoflurane-sufentanil (SS) or propofol-remifentanil (PR) administered during craniotomy for STT. MATERIALS AND METHODS:: After IRB approval and written consent, patients scheduled for surgical removal of STT were randomized to receive PR or SS. Anesthesia was adjusted to maintain BIS values between 45 and 55. The primary outcome was the time from discontinuation of anesthetics to extubation. Secondary endpoints were: time to respond to a simple order, and to achieve spontaneous ventilation, agitation score at emergence, postoperative Mini Mental State, postoperative Aldrete score, pain Visual Analogical Score, simplified sedation score, Glasgow Coma Scale, and surgical complications. Statistical analyses were performed using analysis of variance. RESULTS:: Thirty-five and 31 were included in the SS and PR groups, respectively. Times to extubation was not different between the 2 groups (11.8±6.9 vs. 13.0±8.1 min in PR and SS groups, respectively, P=0.577). Although times to achieve an Aldrete score to 10, a Glasgow Coma Scale to 15, and a MMS to 30 significantly were lower in SS group, no significant difference was found when analyzing time course of these 3 factors over the first postoperative day. All other secondary endpoints were not different between the 2 groups. CONCLUSION:: During craniotomy for STT, we could not demonstrate a reduction in the time to extubation when comparing a BIS-guided anesthesia associating PR to a BIS-guided anesthesia associating SS (Clinicatrials.gov identifier: NCT00389883).
机译:引言:幕上肿瘤(STT)切除后的快速恢复很重要。短效麻醉药,如丙泊酚和瑞芬太尼可能支持这一目标。这项研究的目的是比较在开颅STT术中给予七氟醚舒芬太尼(SS)或丙泊酚-瑞芬太尼(PR)联合使用的两种双光谱指数(BIS)指导的麻醉方案的恢复率。材料和方法:在IRB批准和书面同意后,计划手术切除STT的患者被随机分配接受PR或SS。调整麻醉以将BIS值维持在45至55之间。主要结局是从停止麻醉到拔管的时间。次要终点为:对简单命令做出反应并达到自发通气的时间,出现时的躁动评分,术后迷你精神状态,术后Aldrete评分,疼痛视觉类比评分,简化的镇静评分,格拉斯哥昏迷评分和手术并发症。使用方差分析进行统计分析。结果:SS组和PR组分别包括35名和31名。两组拔管时间无差异(PR组和SS组分别为11.8±6.9分钟和13.0±8.1分钟,P = 0.577)。尽管SS组的Aldrete评分达到10分,格拉斯哥昏迷评分达到15分,MMS达到30分的时间显着降低,但分析这3个因素在术后第一天的时程并没有显着差异。两组之间的所有其他次要终点没有差异。结论:在进行STT开颅手术期间,当将BIS引导的麻醉性PR与BIS引导的麻醉性SS进行比较时,我们无法证明拔管时间减少(Clinicatrials.gov标识符:NCT00389883)。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号